Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II studyChia-Chi Lin, Yeong‐Shiau Pu, Chao‐Yuan Huang et al.|Anti-Cancer Drugs|2007Cited by 39